Clinical Significance of Hematological Indices as Disease Activity Markers in Patients With Ankylosing Spondylitis Following Treatment With Tumor Necrosis Factor Inhibitors

This study indicated that four hematological indices may be useful markers of disease activity and predictors of treatment response to TNF inhibitors in patients with AS. Further studies in larger populations are needed to validate the usefulness of hematological indices as measures of disease activity in patients with AS.